Chitwood D D, Page J B, Comerford M, Inciardi J A, McCoy C B, Trapido E, Lai S H
Department of Oncology, University of Miami, School of Medicine.
Am J Public Health. 1991 May;81(5):631-3. doi: 10.2105/ajph.81.5.631.
In spite of efforts to dissuade intravenous drug users (IVDUs) from donating or selling blood, some continue to do so. As part of a longitudinal study, 915 IVDUs in South Florida were interviewed concerning their history of donation or sale of blood and tested for antibodies to HIV-1 and HTLV-I/II. Approximately 17 percent had either donated or sold blood during 1985 through 1988; most contributors (80.4 percent) sold to commercial blood services. IVDUs who had donated/sold blood were more likely to be male and not in drug treatment than were those who had not contributed blood. IVDUs not in treatment at the time of interview were more likely than IVDUs in treatment to have sold blood. Of those who had donated/sold blood since 1985, 19.6 percent subsequently tested positive for antibodies to HIV-1 and 5.7 percent were positive for antibodies to HTLV-I/II. Increased effort is required to screen prospective donors and sellers, particularly at commercial blood banks.
尽管已努力劝阻静脉注射吸毒者(IVDUs)献血或卖血,但仍有一些人继续这样做。作为一项纵向研究的一部分,对南佛罗里达州的915名静脉注射吸毒者就其献血或卖血史进行了访谈,并检测了他们是否有抗HIV-1和抗HTLV-I/II抗体。在1985年至1988年期间,约17%的人曾献血或卖血;大多数献血者(80.4%)将血卖给了商业血液机构。与未献血的静脉注射吸毒者相比,献血/卖血的静脉注射吸毒者更可能为男性且未接受戒毒治疗。在接受访谈时未接受治疗的静脉注射吸毒者比接受治疗的静脉注射吸毒者更有可能卖血。自1985年以来献血/卖血的人中,19.6%后来抗HIV-1抗体检测呈阳性,5.7%抗HTLV-I/II抗体呈阳性。需要加大力度对潜在的献血者和卖血者进行筛查,尤其是在商业血库。